Streetbeat News

Stock Prices

CVX

Whale investors have shown a mixed sentiment towards Chevron (NYSE:CVX), with options trading indicating a split between bullish and bearish positions. Benzinga's options scanner revealed 14 unusual trades, with a price target range of $130.0 to $155.0 for CVX over the next three months. The trading volume and open interest in Chevron's options suggest significant investor interest, particularly in puts, which have seen larger total trade prices compared to calls. Chevron's current market status shows a slight increase in stock price, with an upcoming earnings report in 49 days.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 8:30 pm

CAT

$1000 invested in CATCo Reinsurance Opportunities Fund Ltd (NYSE:CAT) 15 years ago would now be worth $12,700.52, showcasing an annualized return of 18.57% and outperforming the market by 4.98%. CATCo has a current market cap of $170.84 billion.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 8:30 pm

ASML

ASML Holding (NASDAQ:ASML) has significantly outperformed the market over the past 5 years, with an annualized return of 27.61% and an average annual return of 40.52%, growing a $1000 investment to $5,522.70. The company's current market capitalization stands at $408.95 billion.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 8:30 pm

ACLS

AMAT

ANET

ARM

ASX

CISO

DELL

HOLO

MOBX

MPWR

NVTS

QIWI

SMX

SNOW

Shares of technology sector companies are trading lower, indicating a possible overall pullback in tech stocks.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 8:26 pm

CCL

Carnival Corporation's stock (CCL) is trading higher following an upgrade from Stifel, which raised its price target from $25 to $26, citing the stock's recent underperformance compared to peers as a buying opportunity.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 8:14 pm

AVGO

MRVL

Semiconductor stocks are trading lower after Broadcom and Marvell reported their quarterly earnings, leading to a sector-wide pullback. The sector may also experience volatility due to anticipation of CHIPS act subsidies.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 8:08 pm

MEDP

Medpace Holdings (NASDAQ:MEDP) has received diverse analyst ratings over the last three months, with a shift towards a more bullish outlook. The average 12-month price target for MEDP has increased by 22.55% to $413.0. Analysts from UBS and Baird have raised their price targets, reflecting positive sentiment towards the company's performance, including a solid revenue growth rate of 26.47% and a high net margin of 15.7%. Medpace, a contract research organization, has shown strong financial management with an ROE of 15.2% and an ROA of 4.98%.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 8:01 pm

SYRA

Syra Health's (NYSE:SYRA) short interest has decreased by 39.6%, with 84 thousand shares sold short, representing 2.12% of its float. This decrease in short interest could indicate a more bullish sentiment towards SYRA among traders. The company's short interest is higher than its peer group average of 1.76%, suggesting a mixed sentiment when compared to its peers.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 8:00 pm

AWK

American Water Works (NYSE:AWK) has seen a 22.39% increase in short interest since its last report, with 2.82 million shares sold short, representing 1.64% of its float. This compares to a peer group average of 1.59%. The rise in short interest suggests a more bearish market sentiment towards AWK, but it's also noted that increasing short interest can sometimes be bullish.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 8:00 pm

Over the past 10 years, Fabrinet (NYSE:FN) has significantly outperformed the market, with an average annual return of 27.42%, turning a $1000 investment into $10,968.17. Currently, Fabrinet's market capitalization stands at $8.09 billion.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 8:00 pm